PTEN transcriptionally modulates c-myc gene expression in human breast carcinoma cells and is involved in cell growth regulation

Gene

Volumn 235, Issue 1-2, 1999, Pages 85-91

  Ghosh, A K ^a   Grigorieva, I ^a   Steele, R ^a   Hoover, R G ^a   Ray, R B ^a,b  

^a School of Medicine   (United States)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Proliferation; PTEN; Transcription; Tumorigenicity

Indexed keywords

PROTEIN KINASE B;

ADENOVIRUS; APOPTOSIS; ARTICLE; BREAST CARCINOMA; CARCINOGENICITY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; ONCOGENE C MYC; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

ADENOVIRIDAE; MUS MUSCULUS;

EID: 0032775391     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1119(99)00206-1     Document Type: Article

References (35)

1. Alessi D.R., Dean M., Casamayor H., Caudwell F.B., Morrice N., Norman D.G., Gaffney P., Reese C.B., MacDougall C.N., Harbison D., Ashworth A., Bownes M. 3-phosphoinositide-dependent protein kinase-1 (PDK-1): structural and functional homology with the Drosophila DSTPK61 kinase. Curr. Biol. 7:1997;776-789.
2. Anton M., Graham F.L. Site-specific recombination mediated by an adenovirus vector expressing the Cre recombinase protein: a molecular switch for control of gene expression. J. Virol. 69:1995;4600-4606.
3. Cheney I.W., Johnson D.E., Vaillancourt M.T., Avanzini J., Morimoto A., Demers G.W., Wills K.N., Shabram P.W., Bolen J.B., Tavtigian S.V., Bookstein R. Suppresion of tumorigenicity of glioblastoma cells by adenovirus-mediated MMAC1/PTEN gene transfer. Cancer Res. 58:1998;2331-2334.
4. Clayman G.L., El-Naggar A.K., Roth J.A., Zhang W.-W., Goepfert H., Taylor D.L., Liu T.-J. In vivo molecular therapy with p53 adenovirus for microscopic residual head and neck squamous carcinoma. Cancer Res. 55:1995;1-6.
5. Cole. The c-myc oncogene: Its role in transformation and differentiation. Annu. Rev. Genet. 20:1986;361-384.
6. Davies M.A., Lu Y., Sano T., Fang X., Tang P., LaPushin R., Koul D., Bookstein R., Stokoe D., Yung W.K.A., Mills G.B., Steck P.A. Adenoviral transgene expression of MMAC1/PTEN in human glioma cells inhibits Akt activation and induces anoikis. Cancer Res. 58:1998;5285-5290.
7. Devilee P., Schuuring E., van de Vijver M.J., Cornelisse C.J. Recent development in the molecular genetic understanding of breast cancer. Crit. Rev. Oncog. 5:1994;247-270.
8. Downward J. Mechanisms and consequences of activation of protein kinase B/Akt. Curr. Opin. Cell Biol. 10:1998;262-267.
9. Dubik D., Dembinski T.C., Shiu R.P.C. Stimulation of c-myc oncogene expression associated with estrogen-induced proliferation of human breast cancer cells. Cancer Res. 47:1987;6517-6521.
10. Dubik D., Shiu R.P.C. Transcriptional regulation of c-myc oncogene expression by estrogen in hormone-responsive human breast cancer cells. J. Biol. Chem. 263:1988;12705-12708.
11. Furnari F.B., Lin H., Huang H.J.S., Cavenee W.K. Growth suppression of glioma cells by PTEN requires a functional phosphatase catalytic domain. Proc. Natl. Acad. Sci. USA. 94:1997;12479-12484.
12. Hamburger A.W., Salmon S.E. Development of a bioassay for human myeloma colony-forming cells. Prog. Clin. Biol. Res. 48:1980;23-41.
13. He T.-C., Zhou S., da Costa L.T., Yu J., Kinzler K., Vogelstein B. A simplified system for generating recombinant adenovirus. Proc. Natl. Acad. Sci. USA. 95:1998;2509-2514.
14. Kauffman-Zeh A., Rodriguez-Viciana P., Ulrich E., Gilbert C., Coffer P., Downward J., Evan G. Suppression of c-myc-induced apoptosis by Ras signaling through PI(3)K and PKB. Nature. 385:1997;544-548.
15. Lasko D., Cavenee W.K., Nordenskjold M. Loss of constitutional heterozygosity in human cancer. Annu. Rev. Genet. 25:1991;281-314.
16. Levy N., Yowish-Rouach Y., Oren M., Kimychi A. Complementation by wild-typr p53 of interleukin-6 effects on M1 cells: induction of cell cycle exit and cooperativity with c-myc suppression. Mol. Cell. Biol. 13:1993;7942-7952.
17. Li D.M., Sun H. TEPI, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor β Cancer Res. 57:1997;2124-2129.
18. Li J., Yen C., Liaw D., Podsypanina K., Bose S., Wang S., Puc J., Milliaresis C., Rodgers L., McCombie R., Bigner S.H., Giovanella B.C., Ittmann M., Tycko B., Hibshoosh H., Wigler M.H., Parsons R. PTEN, a putative protein tyrosine phosphate gene muluted in human brain, breast and prostate cancer. Science. 275:1997;1943-1946.
19. Li J., Simpson L., Takahashi M., Miliaresis C., Myers M.P., Tonks N., Parsons R. The PTEN/MMAC1 tumor suppressor induces cell death that is rescued by AKT/Protein Kinase B oncogene. Cancer Res. 58:1998;5667-5672.
20. Liaw D., Marsh D.J., Li J., Dahia P.L.M., Wang S.I., Zheng Z., Bose S., Call K.M., Tsou H.C., Peacocke M., Eng C., Parsons R. Germline mutations of the PTEN gene in Cowden disease, an inheritied breast and thyroid cancer syndrome. Nat. Genet. 16:1997;64-67.
21. Maehama T., Dixon J.E. The tumor suppressor, PTEN/MMACI, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-triphosphate. J. Biol. Chem. 273:1998;13375-13378.
22. March D.J., Dahia P.L., Liaw D., Parsons R., Gorlin R.J., Eng C. Germline mutations in PTEN are present in Bannayan-Zonana syndrome. Nat. Genet. 16:1997;333-334.
23. Morgan R.A., Anderson W.F. Human gene therapy. Annu. Rev. Biochem. 62:1993;191-217.
24. Myers M.P., Stolarov J.P., Eng C., Li J., Wang S.I., Wigler M.H., Parsons R., Tonks M.K. P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase. Proc. Natl. Acad. Sci. USA. 94:1997;9052-9057.
25. Pavelic Z.P., Steele P., Preisler H.D. Evaluation of c-myc protooncogene in primary human breast carcinomas. Anticancer Res. 11:1991;1421-1427.
26. Ray R.B., Miller D.M. Cloning and characterization of a human c-myc promotor-binding protein. Mol. Cell. Biol. 11:1991;2154-2161.
27. Ray R. Induction of cell death in murine fibroblasts by a c-myc promoter binding protein. Cell Growth Differ. 6:1995;1089-1096.
28. Ray R.B., Steele R., Seftor E., Hendrix M. Human breast carcinoma cells transfected with the gene encoding a c-myc promoter-binding protein (MBP-1) inhibits tumors in nude mice. Cancer Res. 55:1995;3747-3751.
29. Schoenenberger C.-A., Andres A.-C., Groner B., van der Valk M., Lemeur M., Gerlinger P. Targeted c-myc gene expression in mammary glands of transgenic mice induces mammary tumors with constitutive milk protein gene transcription. EMBO J. 7:1988;169-175.
30. Spandidos D.A., Field J.K., Agnantis N.J., Evan G.I., Moore J.P. High levels of c-myc protein in human breast tumors determined by a sensitive ELISA technique. Anticancer Res. 9:1989;821-826.
31. Spencer C.A., Gourdine M. Control of c-myc regulation in normal and neoplastic cells. Adv. Cancer Res. 53:1991;1-48.
32. Steck P.A., Pershouse M.A., Jasser S.A., Yung W.K.A, Lin H., Ligon A.H., Langford L.A., Baumgard M.L., Hattier T., Davis T., Frye C., Hu R., Swedlund B., Teng D.H.F., Tavtigian S.V. Identification of a candidate tumor suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat. Genet. 15:1997;356-362.
33. Stokoe D., Stephens L.R., Copeland T., Gaffney P.R., Reese C.B., Painter G.F., Holmes A.B., McCormick F., Hawkins P.T. Dual role of phosphatidylinositol-3,4,5-triphosphate in the activation of protein kinase B. Science. 277:1997;567-570.
34. Tamura M., Gu J., Matsumoto K., Aota S., Parsons R., Yamada K.M. Inhibition of cell migration, spreading, and focal adgesions by tumor suppressor PTEN. Science. 280:1998;1614-1617.
35. Wingo P.A., Tong T., Bolden S. Cancer statistics Ca:a. Cancer J. Clin. 45:1995;8-30.